Cytori Cell Research Institute, Inc. (3750) Stock Statistics & Valuation Metrics

Cytori Cell Research Institute, Inc. has a market cap or net worth of ¥6.50B. The enterprise value is ¥8.11B.

Cytori Cell Research Institute, Inc. has 8,929,419 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cytori Cell Research Institute, Inc.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 1.96%.

The current PE Ratio of Cytori Cell Research Institute, Inc. is 61.14. Cytori Cell Research Institute, Inc.’s PEG ratio is 0.69.

In the last 12 months, Cytori Cell Research Institute, Inc. had revenue of 1.56B and earned 138.16M in profits. Earnings per share was 15.44.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Cytori Cell Research Institute, Inc. pays an annual dividend of ¥10, resulting in a dividend yield of ―

Cytori Cell Research Institute, Inc. upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

Cytori Cell Research Institute, Inc. as a current ratio of 2.66, with Debt / Equity ratio of 131.81%

In the past 12 months, Cytori Cell Research Institute, Inc. has paid -1.15B in taxes.

Cytori Cell Research Institute, Inc. EV to EBITDA ratio is -16.38, with an EV/FCF ratio of -8.46.

Cytori Cell Research Institute, Inc. has ¥443.00M in cash and marketable securities with ¥2.66B in debt, giving a net cash position of ¥2.22B billion.

Gross margin is 49.14%, with operating margin of -49.52%, and net profit margin of 8.85%.

The average price target for Cytori Cell Research Institute, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―